Fuxiang Pharmaceutical: Announcement on the investment and establishment of a subsidiary company by its holding subsidiary and the completion of industrial and commercial registration
Securities code: 300497 Securities abbreviation: Fuxiang Pharmaceutical Announcement number: 2025-063
Jiangxi Fuxiang Pharmaceutical Co., Ltd.
Announcement on the investment and establishment of a subsidiary company by a holding subsidiary and the completion of industrial and commercial registration
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
1. Overview of foreign investment
Jiangxi Fuxiang Biotechnology Co., Ltd., a holding subsidiary of Jiangxi Fuxiang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), established Weiran Business Alliance (Shanghai) Food Technology Co., Ltd. with its own funds, with a registered capital of RMB 10 million. According to the "Shenzhen Stock Exchange GEM Stock Listing Rules", "Shenzhen Stock Exchange Listed Companies Self-Regulatory Guidelines No. 2 - Standardized Operations of GEM Listed Companies" and the "Articles of Association" and other relevant regulations, this investment did not meet the deliberation standards of the board of directors and shareholders' meeting, nor was it a related transaction or major asset restructuring matter.
2. Basic information on establishing Sun Company
Recently, Weiran Business Alliance (Shanghai) Food Technology Co., Ltd. has completed the industrial and commercial registration procedures and obtained the "Business License" issued by the Market Supervision and Administration Bureau of Xuhui District, Shanghai. The main information is as follows:
Company name: Weiran Business Alliance (Shanghai) Food Technology Co., Ltd.
Unified social credit code: 91310104MAEXR98W72
Residence: Room 2809A, No. 777, Hongqiao Road, Xuhui District, Shanghai
Enterprise type: other limited liability company
Legal representative: JIZU JOHNCHENG (Cheng Jianzu)
Registered capital: RMB 10 million
Date of establishment: September 23, 2025
Business scope: General projects: technical services, technology development, technical consultation, technology exchange, technology transfer, technology promotion; retail of pet food and supplies; import and export of goods. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law) Licensed projects: food sales; food Internet sales. (Projects that require approval according to law can only be carried out with the approval of relevant departments. Specific business projects shall be subject to the approval documents or licenses of relevant departments)
Investment method: currency investment
Investors and investment ratio: Jiangxi Fuxiang Biotechnology Co., Ltd., holding 100% of the shares
3. Purpose of external investment, existing risks and impact on the company
The establishment of Weiran Business Alliance (Shanghai) Food Technology Co., Ltd. aims to rely on Shanghai’s location advantages in the Yangtze River Delta Economic Belt and the international economic and cultural center to build the industry’s only open commercialization entity for technology transformation and create the “Weiran New Quality Protein Joint Innovation Business Alliance”. The Lianchuang Business Alliance will set up short-term and long-term business alliance mechanisms for settled products and brands, including customized incubation of brand building, product development and marketing, and efficiently promote biotechnology transformation (application of new protein raw materials) to product commercialization and internationalization. Overseas brands will be introduced in the early stage. With the recognition and approval of domestic new protein and new food raw materials, many domestic brands will also join the alliance one after another, thus forming a new pattern of coordinated development of domestic and international dual markets and two-wheel drive, and joint creation to build a moat for the new protein industry.
Weiran Business Alliance (Shanghai) Food Technology Co., Ltd. may be subject to certain risks in the future due to factors such as changes in the market environment, industry policy adjustments, and business management challenges. The company will take this investment as an opportunity to continue to optimize resource allocation, improve the company's overall operating efficiency and profitability, and effectively control and prevent related risks.
4. Documents for reference
"Business License of Weiran Business Alliance (Shanghai) Food Technology Co., Ltd."
Announcement is hereby made.
Board of Directors of Jiangxi Fuxiang Pharmaceutical Co., Ltd.
September 25, 2025